Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 Feb;81(2):153–159. doi: 10.1136/hrt.81.2.153

Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course

Y Yazaki 1, M Isobe 1, W Takahashi 1, H Kitabayashi 1, O Nishiyama 1, M Sekiguchi 1, T Takemura 1
PMCID: PMC1728928  PMID: 9922350

Abstract

Objective—To determine the clinical and prognostic value of identifying metabolic abnormalities of myocardial fatty acid metabolism in idiopathic dilated cardiomyopathy using iodine-123 β-methyl-iodophenyl pentadecanoic acid (123I BMIPP).
Setting—Cardiac care division in national hospital.
Patients—32 consecutive patients with idiopathic dilated cardiomyopathy in whom both 123I BMIPP and thallium-201 myocardial single photon emission computed tomography were performed.
Methods—The uptake of each tracer was scored visually from 0 (normal) to 3 (defect) in 17 segments (eight basal, eight midventricular, and one apical). A total score for all 17 segments was compared with clinicopathological variables. Prognostic value of mismatches between the two tracers were also evaluated.
Results—The 123I BMIPP total score was correlated with pulmonary capillary wedge pressure (r = 0.68, p < 0.001), left ventricular end diastolic pressure (r = 0.65, p < 0.001), percentage fractional shortening at six months' follow up (r = -0.58, p = 0.001), myocyte diameter (r = 0.66, p < 0.001), and percentage area of interstitial fibrosis (r = 0.69, p < 0.001) measured by morphometry in the biopsy specimens. During a mean (SD) follow up of 20 (11) months, deterioration of the New York Heart Association functional class was observed in 11 of the 32 patients; four of these died. Segments with a greater decrease in 123I BMIPP than thallium-201 uptake (type B mismatching) were often observed in patients with deterioration (88/187, 29% v 58/357, 16%; p < 0.001).
Conclusions—The extent of the abnormality of myocardial fatty acid metabolism in idiopathic dilated cardiomyopathy reflects the severity of haemodynamic deterioration and histopathological changes. Type B mismatching is one of the important prognostic indicators in idiopathic dilated cardiomyopathy.

 Keywords: idiopathic dilated cardiomyopathy; fatty acid metabolism; β-methyl-iodophenyl pentadecanoic acid

Full Text

The Full Text of this article is available as a PDF (154.4 KB).

Figure 1  .

Figure 1  

Open in a new tab

Segments used for SPECT data analysis. Anterior = segments 2, 9, 10, 17; lateral = segments 3, 4, 11, 12; inferior = segments 5, 6, 13, 14; septal = segments 7, 8, 15, 16; apical = 1. 

Figure 2  .

Figure 2  

Open in a new tab

A representative case of type B mismatching in the interventricular septum. A 64 year old female patient showed complete right bundle branch block. Short axis and horizontal images with 123I BMIPP and thallium-201 SPECT show type B mismatching in the intraventricular septum (arrowheads). Since this patient showed a decrease in exercise capacity and an increase in the cardiothoracic ratio from 52% to 57% during the follow up period, treatment with β blockade was begun.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baandrup U., Olsen E. G. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects. Br Heart J. 1981 May;45(5):475–486. doi: 10.1136/hrt.45.5.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Geeter F., Franken P. R., Knapp F. F., Jr, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med. 1994 Apr;21(4):283–291. doi: 10.1007/BF00947962. [DOI] [PubMed] [Google Scholar]
  3. Doi Y. L., Chikamori T., Tukata J., Yonezawa Y., Poloniecki J. D., Ozawa T., McKenna W. J. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am J Cardiol. 1991 Jan 15;67(2):188–193. doi: 10.1016/0002-9149(91)90443-o. [DOI] [PubMed] [Google Scholar]
  4. Franken P. R., De Geeter F., Dendale P., Demoor D., Block P., Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med. 1994 Nov;35(11):1758–1765. [PubMed] [Google Scholar]
  5. Fujibayashi Y., Yonekura Y., Takemura Y., Wada K., Matsumoto K., Tamaki N., Yamamoto K., Konishi J., Yokoyama A. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med. 1990 Nov;31(11):1818–1822. [PubMed] [Google Scholar]
  6. Geltman E. M., Smith J. L., Beecher D., Ludbrook P. A., Ter-Pogossian M. M., Sobel B. E. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography. Am J Med. 1983 May;74(5):773–785. doi: 10.1016/0002-9343(83)91065-3. [DOI] [PubMed] [Google Scholar]
  7. Höck A., Freundlieb C., Vyska K., Lösse B., Erbel R., Feinendegen L. E. Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med. 1983 Jan;24(1):22–28. [PubMed] [Google Scholar]
  8. Knapp F. F., Jr, Ambrose K. R., Goodman M. M. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med. 1986;12 (Suppl):S39–S44. doi: 10.1007/BF00258103. [DOI] [PubMed] [Google Scholar]
  9. Kurata C., Tawarahara K., Taguchi T., Aoshima S., Kobayashi A., Yamazaki N., Kawai H., Kaneko M. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med. 1992 Jan;33(1):6–13. [PubMed] [Google Scholar]
  10. Matsunari I., Fujino S., Taki J., Senma J., Aoyama T., Wakasugi T., Hirai J., Saga T., Ichiyanagi K., Hisada K. Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection. Am Heart J. 1996 Mar;131(3):458–465. doi: 10.1016/s0002-8703(96)90523-2. [DOI] [PubMed] [Google Scholar]
  11. Matsunari I., Saga T., Taki J., Akashi Y., Hirai J., Wakasugi T., Aoyama T., Matoba M., Ichiyanagi K., Hisada K. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med. 1994 Aug;35(8):1279–1285. [PubMed] [Google Scholar]
  12. Morishita S., Kusuoka H., Yamamichi Y., Suzuki N., Kurami M., Nishimura T. Kinetics of radioiodinated species in subcellular fractions from rat hearts following administration of iodine-123-labelled 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (123I-BMIPP). Eur J Nucl Med. 1996 Apr;23(4):383–389. doi: 10.1007/BF01247365. [DOI] [PubMed] [Google Scholar]
  13. Nakata T., Tanaka S., Hamagami S., Miyamoto K., Oh-hori K., Iimura O. Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP. J Nucl Med. 1996 Oct;37(10):1679–1681. [PubMed] [Google Scholar]
  14. Nakayama Y., Shimizu G., Hirota Y., Saito T., Kino M., Kitaura Y., Kawamura K. Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol. 1987 Jul;10(1):186–192. doi: 10.1016/s0735-1097(87)80178-x. [DOI] [PubMed] [Google Scholar]
  15. Opie L. H. Metabolism of the heart in health and disease. I. Am Heart J. 1968 Nov;76(5):685–698. doi: 10.1016/0002-8703(68)90168-3. [DOI] [PubMed] [Google Scholar]
  16. Redfield M. M., Gersh B. J., Bailey K. R., Ballard D. J., Rodeheffer R. J. Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol. 1993 Dec;22(7):1921–1926. doi: 10.1016/0735-1097(93)90780-5. [DOI] [PubMed] [Google Scholar]
  17. Rellas J. S., Corbett J. R., Kulkarni P., Morgan C., Devous M. D., Sr, Buja L. M., Bush L., Parkey R. W., Willerson J. T., Lewis S. E. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol. 1983 Dec 1;52(10):1326–1332. doi: 10.1016/0002-9149(83)90596-9. [DOI] [PubMed] [Google Scholar]
  18. Schiller N. B., Shah P. M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358–367. doi: 10.1016/s0894-7317(89)80014-8. [DOI] [PubMed] [Google Scholar]
  19. Schwarz F., Mall G., Zebe H., Schmitzer E., Manthey J., Scheurlen H., Kübler W. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation. 1984 Dec;70(6):923–928. doi: 10.1161/01.cir.70.6.923. [DOI] [PubMed] [Google Scholar]
  20. Takeishi Y., Chiba J., Abe S., Tonooka I., Komatani A., Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med. 1992;19(9):775–782. doi: 10.1007/BF00182819. [DOI] [PubMed] [Google Scholar]
  21. Tamaki N., Kawamoto M., Yonekura Y., Fujibayashi Y., Takahashi N., Konishi J., Nohara R., Kambara H., Kawai C., Ikekubo K. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med. 1992 May;33(5):659–667. [PubMed] [Google Scholar]
  22. Ugolini V., Hansen C. L., Kulkarni P. V., Jansen D. E., Akers M. S., Corbett J. R. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging. Am J Cardiol. 1988 Nov 1;62(13):923–928. doi: 10.1016/0002-9149(88)90894-6. [DOI] [PubMed] [Google Scholar]
  23. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]
  24. Waagstein F., Bristow M. R., Swedberg K., Camerini F., Fowler M. B., Silver M. A., Gilbert E. M., Johnson M. R., Goss F. G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11;342(8885):1441–1446. doi: 10.1016/0140-6736(93)92930-r. [DOI] [PubMed] [Google Scholar]
  25. Yamamichi Y., Kusuoka H., Morishita K., Shirakami Y., Kurami M., Okano K., Itoh O., Nishimura T. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995 Jun;36(6):1043–1050. [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES